Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 3 (2006), Issue 2 (February)

1. DNA methylation patterns in adenomas from FAP, multiple adenoma and sporadic colorectal carcinoma patients.
   Int J Cancer, 118(4): 907-15. [Abstract] [Full-text]
2. Associations between 5,10-methylenetetrahydrofolate reductase codon 677 and 1298 genetic polymorphisms and environmental factors with reference to susceptibility to colorectal cancer: a case-control study in an Indian population.
   Int J Cancer, 118(4): 991-7. [Abstract] [Full-text]
3. Aberrant promoter methylation of multiple genes during multistep pathogenesis of colorectal cancers.
   Int J Cancer, 118(4): 924-31. [Abstract] [Full-text]
4. Minimally invasive sentinel lymph node mapping of the pig colon with Lymphoseek.
   Surgery, 139(2): 217-23. [Abstract] [Full-text]
5. Irinotecan, oxaliplatin plus bolus 5-fluorouracil and low dose folinic acid every 2 weeks: a feasibility study in metastatic colorectal cancer patients.
   Am J Clin Oncol, 29(1): 45-51. [Abstract] [Full-text]
6. The combination of capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancer.
   Am J Clin Oncol, 29(1): 40-4. [Abstract] [Full-text]
7. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.
   JAMA, 295(6): 643-54. [Abstract] [Full-text]
8. c-FLIP inhibits chemotherapy-induced colorectal cancer cell death.
   Oncogene, 25(6): 838-48. [Abstract] [Full-text]
9. DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1.
   J Clin Oncol, 24(5): 805-15. [Abstract] [Full-text]
10. Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose-response study.
    Gut, 55(3): 367-73. [Abstract] [Full-text]
11. A genome wide linkage analysis in Swedish families with hereditary non-familial adenomatous polyposis/non-hereditary non-polyposis colorectal cancer.
    Gut, 55(3): 362-6. [Abstract] [Full-text]
12. A role for cyclic-GMP dependent protein kinase in anoikis.
    Cell Signal, 18(6): 882-8. [Abstract] [Full-text]
13. Angiogenesis and p53 at the invading tumor edge: prognostic markers for colorectal cancer beyond stage.
    J Surg Res, 131(1): 118-23. [Abstract] [Full-text]
14. A comparison of antiangiogenic therapies for the prevention of liver metastases.
    J Surg Res, 131(1): 97-104. [Abstract] [Full-text]
15. The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
    Cancer Chemother Pharmacol, 57(5): 577-83. [Abstract] [Full-text]
16. Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice.
    Cancer Chemother Pharmacol, 57(5): 654-62. [Abstract] [Full-text]
17. Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status.
    J Natl Cancer Inst, 98(4): 285-8. [Abstract] [Full-text]
18. Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir.
    J Natl Cancer Inst, 98(4): 236-44. [Abstract] [Full-text]
19. Antitumor activity of erlotinib in combination with capecitabine in human tumor xenograft models.
    Cancer Chemother Pharmacol, 57(5): 693-702. [Abstract] [Full-text]
20. Calcium plus vitamin D supplementation and the risk of colorectal cancer.
    N Engl J Med, 354(7): 684-96. [Abstract] [Full-text]
21. Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001.
    J Clin Oncol, 24(6): 878-83. [Abstract] [Full-text]
22. Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes.
    J Nutr Biochem, 17(3): 145-56. [Abstract] [Full-text]
23. Local excision of stratified T1 rectal cancer.
    Am J Surg, 191(3): 410-2. [Abstract] [Full-text]
24. A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence.
    Am J Surg, 191(3): 305-10. [Abstract] [Full-text]
25. The leukocyte protein L-plastin induces proliferation, invasion and loss of E-cadherin expression in colon cancer cells.
    Int J Cancer, 118(8): 2098-104. [Abstract] [Full-text]
26. Prevalence of MYH germline mutations in Swiss APC mutation-negative polyposis patients.
    Int J Cancer, 118(8): 1937-40. [Abstract] [Full-text]
27. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted.
    Br J Cancer, 94(4): 578-85. [Abstract] [Full-text]
28. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer.
    Br J Cancer, 94(4): 593-8. [Abstract] [Full-text]
29. Editing of hnRNP K protein mRNA in colorectal adenocarcinoma and surrounding mucosa.
    Br J Cancer, 94(4): 586-92. [Abstract] [Full-text]
30. K-ras mutations in incident sporadic colorectal adenomas.
    Cancer, 106(5): 1036-40. [Abstract] [Full-text]
31. Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism predicts the risk of gastrointestinal toxicity and fatigue induced by irinotecan-based chemotherapy.
    Cancer, 106(5): 1007-16. [Abstract] [Full-text]
32. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma.
    J Am Coll Surg, 202(3): 468-75. [Abstract] [Full-text]
33. Risk factors for anastomotic leakage after surgery for colorectal cancer: results of prospective surveillance.
    J Am Coll Surg, 202(3): 439-44. [Abstract] [Full-text]
34. Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells.
    Carcinogenesis, 27(3): 508-16. [Abstract] [Full-text]
35. Genome-wide differences between microsatellite stable and unstable colorectal tumors.
    Carcinogenesis, 27(3): 419-28. [Abstract] [Full-text]
36. Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.
    Carcinogenesis, 27(3): 454-64. [Abstract] [Full-text]
37. Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K-ras mutations.
    Carcinogenesis, 27(3): 392-404. [Abstract] [Full-text]
38. Predominant T helper type 2-inflammatory responses promote murine colon cancers.
    Int J Cancer, 118(9): 2232-6. [Abstract] [Full-text]
39. TRAIL-induced cell death cooperates with IFN-gamma activation in the graft-versus-tumor effect against colon tumors.
    Int J Cancer, 118(9): 2237-46. [Abstract] [Full-text]
40. Nuclear Maspin expression is associated with response to adjuvant 5-fluorouracil based chemotherapy in patients with stage III colon cancer.
    Int J Cancer, 118(9): 2247-54. [Abstract] [Full-text]
41. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
    J Clin Oncol, 24(7): 1112-8. [Abstract] [Full-text]
42. Transpleurodiaphragmatic cryosurgical ablation for recurrent unresectable colorectal liver metastases.
    J Surg Oncol, 93(4): 268-72. [Abstract] [Full-text]
43. Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model.
    Int J Radiat Oncol Biol Phys, 64(4): 1188-96. [Abstract] [Full-text]
44. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Int J Radiat Oncol Biol Phys, 64(4): 1129-39. [Abstract] [Full-text]
45. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
    Int J Radiat Oncol Biol Phys, 64(4): 1122-8. [Abstract] [Full-text]
46. Expression of caveolin-1 is correlated with Akt-1 in colorectal cancer tissues.
    Exp Mol Pathol, 80(2): 165-70. [Abstract] [Full-text]
47. 9-Hydroxystearic acid interferes with EGF signalling in a human colon adenocarcinoma.
    Biochem Biophys Res Commun, 342(2): 585-8. [Abstract] [Full-text]
48. Monoclonal antibody A7 coupled to magnetic particles as a contrast enhancing agent for magnetic resonance imaging of human colorectal carcinoma.
    Cancer Immunol Immunother, 55(6): 728-33. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.